Advertisement

Index by author

May 01, 2014; Volume 349,Issue 2

  1. Karlsson, Lars

    1. Clinical and Preclinical Characterization of the Histamine H4 Receptor Antagonist JNJ-39758979
      Robin L. Thurmond, Bin Chen, Paul J. Dunford, Andrew J. Greenspan, Lars Karlsson, David La, Peter Ward and Xie L. Xu
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 176-184; DOI: https://doi.org/10.1124/jpet.113.211714

  2. Katz, Jonathan L.

    1. 2-Isoxazol-3-Phenyltropane Derivatives of Cocaine: Molecular and Atypical System Effects at the Dopamine Transporter
      Takato Hiranita, Derek S. Wilkinson, Weimin C. Hong, Mu-Fa Zou, Theresa A. Kopajtic, Paul L. Soto, Carl R. Lupica, Amy H. Newman and Jonathan L. Katz
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 297-309; DOI: https://doi.org/10.1124/jpet.113.212738

  3. Kim, Ki Hyung

    1. Silibinin Induces Cell Death through Reactive Oxygen Species–Dependent Downregulation of Notch-1/ERK/Akt Signaling in Human Breast Cancer Cells
      Thae Hyun Kim, Jae Suk Woo, Yong Keun Kim and Ki Hyung Kim
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 268-278; DOI: https://doi.org/10.1124/jpet.113.207563

  4. Kim, Thae Hyun

    1. Silibinin Induces Cell Death through Reactive Oxygen Species–Dependent Downregulation of Notch-1/ERK/Akt Signaling in Human Breast Cancer Cells
      Thae Hyun Kim, Jae Suk Woo, Yong Keun Kim and Ki Hyung Kim
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 268-278; DOI: https://doi.org/10.1124/jpet.113.207563

  5. Kim, Yong Keun

    1. Silibinin Induces Cell Death through Reactive Oxygen Species–Dependent Downregulation of Notch-1/ERK/Akt Signaling in Human Breast Cancer Cells
      Thae Hyun Kim, Jae Suk Woo, Yong Keun Kim and Ki Hyung Kim
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 268-278; DOI: https://doi.org/10.1124/jpet.113.207563

  6. Klein, T.

    1. Arginase Inhibition Prevents Inflammation and Remodeling in a Guinea Pig Model of Chronic Obstructive Pulmonary Disease
      T. Pera, A. B. Zuidhof, M. Smit, M. H. Menzen, T. Klein, G. Flik, J. Zaagsma, H. Meurs and H. Maarsingh
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 229-238; DOI: https://doi.org/10.1124/jpet.113.210138

  7. Kondabolu, Krishnakanth

    1. A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses
      Clinton E. Canal, Drake Morgan, Daniel Felsing, Krishnakanth Kondabolu, Neil E. Rowland, Kimberly L. Robertson, Rajeev Sakhuja and Raymond G. Booth
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 310-318; DOI: https://doi.org/10.1124/jpet.113.212373

  8. Kopajtic, Theresa A.

    1. 2-Isoxazol-3-Phenyltropane Derivatives of Cocaine: Molecular and Atypical System Effects at the Dopamine Transporter
      Takato Hiranita, Derek S. Wilkinson, Weimin C. Hong, Mu-Fa Zou, Theresa A. Kopajtic, Paul L. Soto, Carl R. Lupica, Amy H. Newman and Jonathan L. Katz
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 297-309; DOI: https://doi.org/10.1124/jpet.113.212738

  9. Krishnan, Venkatesh

    1. Follistatin: A Novel Therapeutic for the Improvement of Muscle Regeneration
      Benjamin C. Yaden, Johnny E. Croy, Yan Wang, Jonathan M. Wilson, Amita Datta-Mannan, Pamela Shetler, Andrea Milner, Henry U. Bryant, Jessica Andrews, Guoli Dai and Venkatesh Krishnan
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 355-371; DOI: https://doi.org/10.1124/jpet.113.211169
Back to top

In this issue

Advertisement